[Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
D000230:Adenocarcinoma / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000032:analysis*; D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D003536:Cystadenocarcinoma / Q000276:immunology; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000276:immunology*; D012509:Sarcoma / Q000276:immunology
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate